Cargando…
Validation of rapid antibody (IgG-IgM) test kit for SARS-CoV-2 infection in Qatar
Background: In response to the growing coronavirus disease 2019 (COVID-19) pandemic and the shortage of laboratory based molecular testing capacity and reagents, multiple diagnostic test manufacturers have developed rapid and easy to use devices to facilitate testing outside laboratory settings. The...
Autores principales: | Mundodan, Jesha, Hasnain, Samina, Khogali, Hayat, Al Bayat, Soha Shawqi, Ali, Dina, Alateeg, Saif, Al-Romaihi, Hamad Eid, Al Thani, Mohammed Hamad J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874874/ https://www.ncbi.nlm.nih.gov/pubmed/34781629 http://dx.doi.org/10.4081/jphr.2021.2421 |
Ejemplares similares
-
Bordetella pertussis: An agent not to be forgotten in Qatar
por: Hasnain, Samina, et al.
Publicado: (2021) -
Can the cycle threshold (Ct) value of RT-PCR test for SARS CoV2 predict infectivity among close contacts?
por: Al Bayat, Soha, et al.
Publicado: (2021) -
Key Lessons from COVID-19: A Narrative Review Describing Qatar’s Multifactorial Approach in Executing a Vaccination Campaign
por: Albayat, Soha, et al.
Publicado: (2023) -
Development and validation of a multi-dimensional COVID-19 vaccine hesitancy questionnaire
por: Hammoud, Hamed, et al.
Publicado: (2023) -
Pre-symptomatic and asymptomatic transmission of COVID-19: Implications for control measures in Qatar
por: Tawe`ngi, Abdelaziz M, et al.
Publicado: (2021)